ES2510216B1 - CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME - Google Patents

CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME Download PDF

Info

Publication number
ES2510216B1
ES2510216B1 ES201330400A ES201330400A ES2510216B1 ES 2510216 B1 ES2510216 B1 ES 2510216B1 ES 201330400 A ES201330400 A ES 201330400A ES 201330400 A ES201330400 A ES 201330400A ES 2510216 B1 ES2510216 B1 ES 2510216B1
Authority
ES
Spain
Prior art keywords
urolithin
urolitines
elagitanins
converting
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201330400A
Other languages
Spanish (es)
Other versions
ES2510216A1 (en
Inventor
Francisco TOMÁS BARBERÁN
María Victoria SELMA GARCÍA
David Beltrán Riquelme
Juan Carlos ESPÍN DE GEA
Rocío GARCÍA VILLALBA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES201330400A priority Critical patent/ES2510216B1/en
Priority to PCT/ES2014/070207 priority patent/WO2014147280A1/en
Publication of ES2510216A1 publication Critical patent/ES2510216A1/en
Application granted granted Critical
Publication of ES2510216B1 publication Critical patent/ES2510216B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a la identificación por primera vez de microorganismos de origen gastrointestinal humano, que pueden producir urolitinas, a procedimientos de producción de dichos compuestos, al uso de dichos compuestos así producidos en la elaboración de formulaciones alimenticias, farmacéuticas, complementos dietéticos o alimentarios y alimentos funcionales, así como la elaboración de composiciones probióticas mediante la incorporación de microorganismos productores de urolitinas y a un método de aislamiento, de detección y de cuantificación de microorganismos productores de urolitinas basado en el uso de un fragmento de ADN capaz de detectar específicamente los microorganismos productores de urolitinas.The present invention relates to the identification for the first time of microorganisms of human gastrointestinal origin, which can produce urolithins, to production processes of said compounds, to the use of said compounds thus produced in the preparation of food, pharmaceutical, dietary supplements or food and functional foods, as well as the development of probiotic compositions by incorporating urolithin-producing microorganisms and a method of isolation, detection and quantification of urolithin-producing microorganisms based on the use of a DNA fragment capable of specifically detecting urolithin producing microorganisms.

Description



imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

imagen20image20

imagen21image21

imagen22image22

imagen23image23

imagen24image24

imagen25image25

imagen26image26

imagen27image27

imagen28image28

imagen29image29

Claims (1)



 imagen1image 1 imagen2image2 imagen3image3 imagen4image4 imagen5image5 imagen6image6 imagen7image7 imagen8image8
ES201330400A 2013-03-20 2013-03-20 CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME Expired - Fee Related ES2510216B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201330400A ES2510216B1 (en) 2013-03-20 2013-03-20 CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME
PCT/ES2014/070207 WO2014147280A1 (en) 2013-03-20 2014-03-20 Micro-organism that can convert ellagic acid and ellagitannins into urolithins and use of same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201330400A ES2510216B1 (en) 2013-03-20 2013-03-20 CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME

Publications (2)

Publication Number Publication Date
ES2510216A1 ES2510216A1 (en) 2014-10-20
ES2510216B1 true ES2510216B1 (en) 2015-10-27

Family

ID=51579346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201330400A Expired - Fee Related ES2510216B1 (en) 2013-03-20 2013-03-20 CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME

Country Status (2)

Country Link
ES (1) ES2510216B1 (en)
WO (1) WO2014147280A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017014154A (en) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 Hyaluronic acid production promoter containing urolithins
JP6799767B2 (en) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 Melanin production inhibitor containing urolithins
JP6760685B2 (en) * 2016-04-19 2020-09-23 株式会社ダイセル Manufacturing method of urolithins
EP3561067B1 (en) * 2016-12-26 2022-08-03 Daicel Corporation Method for producing urolithins
EP3587571A4 (en) 2017-02-23 2020-11-18 Daicel Corporation Novel microorganism and production method for urolithins using same
WO2019130448A1 (en) * 2017-12-26 2019-07-04 株式会社ダイセル Method for producing urolithins
JP7044574B2 (en) * 2018-01-25 2022-03-30 株式会社ダイセル New lactase
JP2019180283A (en) * 2018-04-06 2019-10-24 株式会社ダイセル Method for producing urolithin
WO2019212997A1 (en) * 2018-04-30 2019-11-07 Rejuvenation Therapeutics Compositions and methods for biosynthetic preparation of urolithin compounds and use thereof
KR20210114929A (en) * 2018-11-05 2021-09-24 마블바이옴 인코포레이티드 Microbial compositions comprising ellagitannins and methods of use
US20220267741A1 (en) 2019-07-25 2022-08-25 Daicel Corporation Enzyme capable of dehydroxylating hydroxyl group in urolithin compound
WO2021119291A1 (en) * 2019-12-10 2021-06-17 Northeastern University Microbial compositions and methods for treatment and detection of disease
WO2022045257A1 (en) 2020-08-28 2022-03-03 株式会社ダイセル Enzyme dehydroxylating hydroxyl group at 9-position of urolithin compound
EP4362955A1 (en) 2021-06-28 2024-05-08 ASC REGENITY Limited Skin care nutraceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2068864B1 (en) * 2006-04-26 2017-08-23 The Regents of the University of California Therapeutic uses of urolithins
EP2654461B1 (en) * 2010-12-23 2018-04-11 Amazentis SA Compositions and methods for treating metabolic disorders

Also Published As

Publication number Publication date
ES2510216A1 (en) 2014-10-20
WO2014147280A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
ES2510216B1 (en) CAPABLE MICROORGANISM OF CONVERTING ELAGIC ACID AND ELAGITANINS IN UROLITINES AND USE OF THE SAME
CL2014001123A1 (en) Anti-il 36r antibodies; pharmaceutical composition that contains it; isolated polynucleotide encoding the antibody; method for antibody production; diagnostic kit that contains it.
EA202092987A2 (en) LIPID CONTAINING DOCOSAPENTAENIC ACID
BR112015006402A2 (en) set of at least one vegetable protein and at least one dairy protein
MX342921B (en) New iridium-based complexes for ecl.
EA201891030A2 (en) Biosafety with the use of strains LACTOBACILLUS RHAMNOSUS
EA201391067A1 (en) PROBIOTICS IN FRUIT DRINKS
CR20170236A (en) METHOD FOR PRODUCING PHARMACEUTICAL ADMINISTRATION SYSTEM, USE OF CALCIUM CARBONATE AND PHARMACEUTICAL ADMINISTRATION SYSTEM OBTAINED BY METHOD
CR20140444A (en) A system and method for the integrated production of first and second generation ethanol, and use of integration points for said production
BR112016030604B8 (en) PROCESS FOR PREPARATION OF 3- HYDROXYPICOLINIC ACIDS
CR20110208A (en) PROCESS FOR THE PREPARATION OF BENZONORBORNENOS
WO2015068075A3 (en) Detection of tau
CL2017001383A1 (en) Process for the manufacture of carboxylic anhydride
MY187748A (en) Compositions and method for maintaining/improving cognitive function
CO7240371A2 (en) Anti-mif immunohistochemistry
WO2013104720A3 (en) Use of ccl23 as brain damage marker
ES2433765B1 (en) Production process of biofuels and food co-products using microalgae culture extracts
MX2016005222A (en) Acid dyes, process for the production thereof and their use.
TH170310A (en) Bio-based acrylic acid and its derivatives
ES2461016B1 (en) Method for the diagnosis and / or prognosis of morbid obesity
AR077017A1 (en) PHYSICAL SAMPLE OF A PRODUCT THAT HAS AT LEAST A PRODUCT SAMPLE CODE.
BR112016001698A2 (en) Production of non-toxic raw materials and finished products tested by a probiotic bacteria-based method to determine toxicity to probiotic bacteria
TH1501002481A (en) Process for producing dietary supplements from probiotic microorganisms from pure cultures.
TH170310B (en) Bio-based acrylic acid and its derivatives
TH147661A (en) Method for producing L-amino acids by using family bacteria Enterobacteriaceae With weak expression of the yjjK gene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2510216

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20151027

FD2A Announcement of lapse in spain

Effective date: 20230726